Updated on: 9 March 2022

Roles in: Haematology Group

1. In the past 36 months have you accepted the following from a commercial organisation with a financial interest in the broad topic area of the Group/Unit?

a) Support for attending meetings, including sabbaticals and study tours (this covers travel, accommodation and/or hospitality)?
Yes - AbbVie, AstraZeneca, Kite-Gilead, Merck Sharp & Dohme, Takeda, and Novartis

b) Payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing, or educational events?
Yes - AstraZeneca, Novartis, Roche Pharma AG, Takeda, and Merck Sharp & Dohme

c) Fees for organising education?
No

d) Grants and contracts?
Yes - Novartis (Inst), Merck Sharp & Dohme (Inst), and Takeda (Inst)

e) Funds for a member of staff?
No

f) Fees for consulting?
Yes - Allogene, BMS/Celgene, Cerus, Incyte, Miltenyi, Novartis, Pentixafarm, Roche, Amgen, Pfizer, Takeda, Merck Sharp & Dohme, and Gilead Kite

g) Royalty or licences payments?
No

h) Payment for expert testimony?
No

i) Payment for a fellowship?
No

j) Payment for participation on a Data Safety Monitoring Board, Advisory Board, or Guideline Panel?
No

k) Payment for a leadership or other fiduciary role in other board, society, committee, or advocacy group?
No

2. In the past 36 months have you, your spouse/partner or an immediate family member been employed by or do you or they own a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

3. Do you own stocks or shares in a commercial organization with a financial interest in the broad topic area of the Group/Unit?
No

4. Do you hold any patents (planned, issued or pending) for products relevant to the broad topic area of the Group/Unit?
No

5. Do you have any other competing interests (financial or non-financial)?
Yes - Member of the following societies: ASH, DGHO, EHA, GLA, GHSG, DGIM, WSG